Auragens

Auragens is a Panama-based biotechnology company specializing in regenerative medicine and advanced stem cell therapies. The company utilizes its proprietary "Golden Cells" selection process to identify specific umbilical cord-derived mesenchymal stem cells (UC-MSCs) with superior anti-inflammatory and regenerative markers. Auragens provides clinical treatments for a variety of chronic conditions, including autism, multiple sclerosis, rheumatoid arthritis, and orthopedic injuries. Their operations include a state-of-the-art laboratory and a specialized clinic designed to deliver high-quality cellular products under rigorous safety standards. By focusing on the immunomodulatory properties of MSCs, Auragens aims to provide non-invasive alternatives for patients with debilitating diseases. The company is closely associated with the pioneering work of Dr. Neil Riordan in the field of cellular medicine.